70121-1570 : Releuko 480 ug/.8ml Intravenous; Subcutaneous Injection, Solution


NDC: 70121-1570
Labeler: Amneal Pharmaceuticals LLC
Product Type: Human Prescription Drug
Drug Name:  Releuko
Dosage Form: Intravenous; Subcutaneous Injection, Solution
Application #: BLA761082
Rev. Date: 


NDC Package Codes:

  • 70121-1570-1: 1 SYRINGE IN 1 BOX (70121‑1570‑1) > .8 ML IN 1 SYRINGE
  • 70121-1570-7: 10 SYRINGE IN 1 BOX (70121‑1570‑7) > .8 ML IN 1 SYRINGE (70121‑1570‑1)

Active Ingredients:

  • Filgrastim

Dosage Strength:

  • 480 ug/.8mL

Pharmaceutical Classes:

  • Granulocyte Colony-Stimulating Factor [CS]
  • Granulocyte-Macrophage Colony-Stimulating Factor [CS]
  • Increased Myeloid Cell Production [PE]
  • Leukocyte Growth Factor [EPC]

Related Products:

Based on records with the same trade name.
  • 70121-1568 Releuko 300 ug/.5ml Intravenous; Subcutaneous Injection, Solution by Amneal Pharmaceuticals LLC
  • 70121-1569 Releuko 300 ug/ml Intravenous; Subcutaneous Injection, Solution by Amneal Pharmaceuticals LLC
  • 70121-1571 Releuko 480 ug/1.6ml Intravenous; Subcutaneous Injection, Solution by Amneal Pharmaceuticals LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 70121-1570 QR Code

< Prev: 70121-1569Next: 70121-1571 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.